The Conversation ·Behind the news
Breakthrough Drug Nearly Doubles Survival with Advanced Pancreatic Cancer – an Oncologist Explains How Daraxonrasib Overcame an ‘undruggable’ Disease
by Christopher Lieu, Professor of Medical Oncology, University of Colorado Anschutz
Published 2026-06-02 17:39:10+00:00
When a cancer is considered "undruggable," what finally changes the narrative?
0:00 / 5:32 · Narrator Charon
Context
Pancreatic cancer has long felt like one of those truly formidable foes in medicine, a diagnosis that often leaves little room for hope. This piece delves into a remarkable shift in that narrative. It's not just about a new drug, daraxonrasib, but what it means to finally target a mechanism previously deemed 'undruggable.' It makes you wonder about the broader implications for other cancers, and how these scientific breakthroughs fundamentally alter our understanding of what's possible in treatment.